Range
- - -
Vol / Avg.
-/654K
Div / Yield
-
52 Wk
101.81 - 189
Mkt Cap
11.2B
Payout Ratio
-
Open
-
P/E
20.09
EPS
2.39
Shares
61M
Outstanding
61M
Total Float
53.1M
load more
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz's product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q1 2021Est.ActualSurprise
EPS3.7403.920 0.1800
REV611.490M607.581M-3.909M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
JAZZJazz Pharmaceuticals0%11.2B

Jazz Pharmaceuticals Frequently Asked Questions

Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by HC Wainwright & Co. on May 17, 2021. The analyst firm set a price target for 212.00 expecting JAZZ to rise to within 12 months (a possible 15.59% upside). 19 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $183.41 last updated Tue Jun 15 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A
Jazz Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 3, 2021.
Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.